Stefania Parlato

Title: Stefania Parlato: Innovator in Dendritic Cell Research

Introduction

Stefania Parlato is a prominent inventor based in Rome, Italy. She has made significant contributions to the field of immunology, particularly in the development of methods for generating dendritic cells. Her innovative work has the potential to enhance therapeutic and prophylactic vaccination strategies for both animals and humans.

Latest Patents

Stefania Parlato holds a patent for a "Method for generating highly active human dendritic cells from peripheral blood mononuclear cells." This invention relates to a process for deriving dendritic cells from mononuclear cells in culture. The method involves contacting type I IFN with the mononuclear cells, resulting in dendritic cells that can serve as cellular adjuvants in vaccination. The invention also includes pharmaceutical compositions, vaccines, and methods for treating pathologies associated with antigens in humans.

Career Highlights

Stefania is affiliated with the Istituto Superiore di Sanità, where she conducts her research. Her work has garnered attention for its innovative approach to enhancing immune responses through dendritic cell manipulation. She has successfully developed a streamlined process that allows for the rapid generation of these cells, which are crucial for effective vaccination.

Collaborations

Stefania collaborates with notable colleagues, including Laura Santodonato and Caterina Lapenta. These partnerships have further enriched her research and contributed to advancements in the field of immunology.

Conclusion

Stefania Parlato's contributions to dendritic cell research exemplify the impact of innovative thinking in the medical field. Her patented methods hold promise for improving vaccination strategies and advancing therapeutic options for various diseases.